IPO News

SpaceX, the rocket manufacturer founded by Elon Musk, is considering a megacap Nasdaq IPO that could value the company at a staggering $1.75 trillion. A listing could occur by June 2026 if the firm secures early inclusion in the Nasdaq 100 index. Meanwhile, Japanese digital payment giant PayPay, backed by SoftBank, successfully debuted on the Nasdaq with a $12.1 billion valuation. IPOX® CEO Josef Schuster noted the company’s unique opportunity to fill a market void despite structural concerns.

The global IPO market is currently heating up with several blockbuster listings in the pipeline. SpaceX is preparing for a record-breaking $50 billion public offering, recently adding Citigroup to its underwriter lineup. In the consumer sector, Roark Capital is weighing a $2 billion IPO for Inspire Brands, the owner of Dunkin'. Meanwhile, Europe anticipates a major boost to the London Stock Exchange as Oaktree Capital Management selects banks for a £2.5 billion listing of wealth management provider Utmost Group Plc.

Elon Musk’s SpaceX is reportedly preparing to confidentially file for a U.S. initial public offering as early as March, aiming for a record-breaking June listing. This highly anticipated share sale could raise up to $50 billion and command a staggering valuation exceeding $1.75 trillion, bolstered by its recent acquisition of the artificial intelligence startup xAI. SpaceX has already aligned major financial institutions, including Bank of America, Goldman Sachs, JPMorgan, and Morgan Stanley, to lead this historic, market-defining public market debut.

The U.S. IPO market faces headwinds as Clear Street and Liftoff Mobile withdraw their listings. IPOX® Associate Lukas Muehlbauer and IPOX® VP Kat Liu noted that AI-driven volatility and crypto declines forced these moves to avoid "failed" IPO stigmas. Meanwhile, Bain Capital explores a $3 billion IPO for Dessert Holdings. In Europe, Thyssenkrupp plans a $13.5 billion materials spin-off, while UI Boustead REIT preps a $788 million Singapore float.

Goldman Sachs predicts a historic $160 billion U.S. IPO boom in 2026, though market volatility is currently testing recent listings. ARKO Petroleum debuted softly at an $808 million valuation, with IPOX® VP Kat Liu noting investors are "approaching deals with caution." Consequently, Clear Street and Agibank recently downsized or postponed their offerings. Globally, mega-deals continue to advance as DayOne targets a $20 billion U.S. listing and PayPay files for $1.5 billion. Meanwhile, IPOX® Associate Lukas Muehlbauer warns of volatility risks amid Saudi Arabia’s retail IPO push.

Nvidia eyes a stake in OpenAI ahead of IPO. IPOX® Associate Lukas Muehlbauer highlights the strength of defense listings following York Space Systems’ $4.75 billion debut, though software volatility forces Liftoff Mobile and Visma to delay. Globally, Syngenta targets a $10 billion Hong Kong deal. Meanwhile, IPOX® CEO Josef Schuster warns on celebrity IPOs, and IPOX® VP Kat Liu analyzes tariff risks for Bob’s Discount Furniture.

SpaceX dominates headlines with a potential $1.5 trillion IPO and xAI merger. Defense firm York Space Systems debuts at $4.75 billion, with IPOX® Associate Lukas Muehlbauer noting the sector’s strength. Muehlbauer also analyzes AI infrastructure play Forgent Power and biotech Eikon Therapeutics. IPOX® VP Kat Liu discusses tariff risks for Bob's Discount Furniture, while IPOX® CEO Josef Schuster warns against celebrity-backed listings. Elsewhere, software firm Anaplan preps a return, and JD.com’s property arm files in Hong Kong.

SpaceX accelerates blockbuster IPO plans by lining up four Wall Street banks, while construction tech firm EquipmentShare hits a $7.2 billion valuation in its Nasdaq debut. IPOX® Associate Lukas Muehlbauer analyzes the deal and crypto custodian BitGo’s volatile start as a 2026 bellwether. The U.S. pipeline grows with filings from prime broker Clear Street and Brazilian fintech Agibank, plus potential moves by Jersey Mike’s and Ledger. Globally, European tank maker KNDS prepares a €25 billion listing, and Alibaba’s chip unit explores a spin-off.

The U.S. IPO pipeline accelerates as construction tech firm EquipmentShare targets a $6.4 billion valuation, with IPOX® VP Kat Liu highlighting its "narrative premium." Crypto custodian BitGo eyes a $2 billion debut, drawing commentary from IPOX® CEO Josef Schuster and Associate Lukas Muehlbauer on market selectivity. Brazilian fintech Agibank files for a $1 billion listing. Globally, Czech defense giant CSG launches a massive €30 billion IPO, while Chinese chipmaker Montage Technology preps a $22 billion Hong Kong debut.

Aktis Oncology surges 24% in the first major biotech IPO of 2026, with IPOX® Associate Lukas Muehlbauer highlighting its strategic backing. The U.S. pipeline accelerates as chat platform Discord and fitness app Strava confidentially file for listings, while President Trump weighs a massive Fannie Mae and Freddie Mac public offering. Additionally, Brazilian fintech PicPay files for a $500 million Nasdaq debut, signaling a robust return of large-cap issuers to the market.

In Europe, Octopus Energy spins off its tech arm Kraken at an $8.7 billion valuation to prepare for a future listing. Asia sees a surge in activity as VinFast affiliate GSM targets a massive $20 billion international IPO. Meanwhile, Chinese tech listings accelerate with Alibaba-backed AI unicorn MiniMax launching its $600 million Hong Kong debut and Baidu’s chip unit Kunlunxin filing for a spin-off, while regulators ease rules for rocket firms like LandSpace.

Bill Ackman proposes a unique SpaceX merger, while Medtronic’s MiniMed and fleet AI firm Motive Technologies file for U.S. debuts. SoftBank delays its PayPay IPO to prioritize OpenAI funding, while China’s LandSpace and pet care group Ringpai advance listing plans. In Europe, Visma expands its syndicate for a blockbuster London deal, and Aegea files to break Brazil’s four-year IPO drought, as Seven & i accelerates its U.S. turnaround.

OpenAI and SpaceX headline the 2026 pipeline with potential $1 trillion+ valuations, fueling Nasdaq’s optimistic outlook. Andersen Group surged 31% in its debut, with IPOX® VP Kat Liu crediting strong brand recognition. In Europe, Elliott preps a London listing for Waterstones and Barnes & Noble. Meanwhile, a wave of Chinese AI and chip firms targets Hong Kong, while Saudi markets cool following EFSIM’s cancellation and CloudKitchens’ delay.

SpaceX dominates headlines with plans for a record-breaking IPO targeting a $1.5 trillion valuation. IPOX® CEO Josef Schuster weighs in on the blockbuster pipeline, while IPOX® Associate Lukas Muehlbauer analyzes Wealthfront’s debut and EquipmentShare’s filing. Tax firm Andersen targets a $1.75 billion deal, Michael Burry eyes a Fannie Mae re-listing, and Magnum completes its spin-off, while Hong Kong sees crypto and robotics activity.

AI takes the lead as Anthropic preps for a potential 2026 IPO and Baidu’s Kunlunxin eyes a Hong Kong listing. IPOX® Associate Lukas Muehlbauer comments on Wealthfront’s $2.05 billion target amid mixed sentiment. Elsewhere, Unilever’s ice cream unit advances spin-off plans, Barrick Gold explores a North American IPO, and Morgan Stanley predicts a dealmaking surge, even as travel unicorn Klook delays its U.S. debut.

Bill Ackman targets a massive $5 billion IPO for a new closed-end fund, while sports tech firm Enhanced agrees to a $1.2 billion SPAC merger. IPOX® CEO Josef Schuster notes the SPAC model’s enduring relevance following the deal. Elsewhere, the UK introduces stamp duty relief to revitalize London listings, and Hong Kong sees a flurry of activity with Syngenta’s potential pivot and new filings from Suzhou Novosense and Muyuan Foods.

Asia-Pacific dominates this week, led by SBI Shinsei Bank’s potential $2.4 billion Tokyo relisting and CK Hutchison’s plan for a $2 billion AS Watson float. Singapore sees UltraGreen.ai targeting $400 million, while the U.S. pipeline heats up with crypto giant Kraken filing for a 2026 debut and Grayscale seeking a NYSE spot. MENA activity is strong with Saudi Global Ports eyeing $1 billion. Meanwhile, Uzbekistan’s sovereign fund prepares for a historic London listing, signaling renewed global momentum across diverse sectors.

Global IPO activity intensifies with major U.S. filings including Blackstone-backed Copeland ($4.75B revenue), Grayscale ($35B AUM), and SoftBank-backed Klook ($417M revenue). Asia-Pacific markets see SBI Shinsei Bank's $2.1 billion Tokyo offering and Kbank's third KOSPI attempt. European developments feature BASF's 2027 Frankfurt listing plans and Bending Spoons eyeing a 2026 U.S. IPO at $11 billion valuation. IPOX analysts highlighted travel sector opportunities and cautioned about market volatility.

This week's IPO activity featured significant U.S. SPAC deals, including Dubai hookah maker AIR's $1.75 billion Nasdaq listing and Xanadu Quantum's $3.6 billion merger. Aeromexico successfully debuted on NYSE at a $2.8 billion valuation. International markets saw Malaysia's Sunway Healthcare planning a $1 billion IPO, while Germany's Mobile.de attracted interest ahead of a potential €10 billion listing. IPOX analysts highlighted SPAC revival momentum and MENA market valuation challenges.

OpenAI targets a record-breaking $1 trillion valuation, Medline files for a $50 billion listing, and Gloo Holdings readies a Nasdaq debut at $873 million. Meanwhile, the UK’s Doncasters eyes a 2026 New York offering, KR1 plans a London uplisting, and Pollon Life, backed by Jack Ma, files in Hong Kong, signaling renewed global confidence in major listings across regions.

In the U.S., a potential Fannie Mae IPO by late 2025 and WestJet’s planned listing highlight optimism despite the government shutdown halting DeepGreenX’s debut. Europe sees EDF exploring a €7–10B Edison IPO and Poland’s Empik eyeing €200M. Asia-Pacific dominates with Yangtze Memory’s possible $40B listing, Haier’s $500M IoT spinout, and multiple Hong Kong, Singapore, and Tokyo deals. In MENA, Dubizzle postponed its $2B Dubai IPO amid weak market sentiment.

IPO activity accelerates despite the U.S. government shutdown. In the U.S., Medline targets a ~$5B float, PayPay eyes a December listing above $20B, Navan and Beta advance sizable offerings, and Exzeo launches on NYSE. Europe sees CSG and Shawbrook preparing deals, while Asia-Pacific features Seres, WeRide, Rakuten Card, Coca-Cola’s HCCB, and I-Mab’s dual listing. MENA’s Dubizzle opens a ~$600M Dubai IPO. IPOX® CEO Josef Schuster urges flexible terms amid volatility.

Global IPO activity is accelerating across regions, led by biotech and AI firms in the U.S., major industrial listings in Europe, and robotics and infrastructure plays in Asia. MENA markets also see renewed momentum with Dubai and Johannesburg offerings on deck. Commentary from IPOX® CEO Josef Schuster and IPOX® Analyst Lukas Muehlbauer underscores strong investor sentiment and strategic timing as issuers navigate regulatory hurdles and capitalize on market windows.

Global IPO markets are regaining momentum across regions, with billion-dollar deals in the U.S., Europe, Asia, and MENA. Highlights include Verisure’s €3.1B raise in Stockholm, MRI Software’s potential $10B U.S. float, and Ottobock’s €800M Frankfurt listing. Meanwhile, fintech Wealthfront, Navan, and University of Phoenix’s owner have filed in the U.S. Strong demand persists, though risks remain, as IPOX® analysts warn pricing discipline and U.S. government shutdown delays could stall activity.

Global IPO activity is surging across regions in 2025. In the U.S./Canada, Medline eyes a $5B blockbuster, Neptune Insurance targets $2.76B, and Brookfield-backed Rockpoint advances in Toronto, with IPOX® VP Kat Liu offering insights. Europe sees Kingspan and Deutsche Börse prepping listings, while Zijin Gold leads Asia-Pacific with a $3.2B Hong Kong float. MENA/Africa highlights Kenya Pipeline’s planned $1.15B IPO and Dubai’s ALEC, amid renewed momentum tracked by IPOX® benchmarks.

In the U.S., Netskope, StubHub, Pattern Group, and SoftBank’s PayPay highlight renewed activity, with IPOX® CEO Josef Schuster, VP Kat Liu, and Associate Lukas Muehlbauer providing insights on selectivity and market resilience. Europe is seeing momentum from Verisure, SMG, Ottobock, and SumUp, while Asia-Pacific is led by multi-billion offerings from Zijin Gold, Chery, and MMC Port. MENA activity includes real estate listings from Dubai Investments and ALEC Holdings.

Global IPO activity is reaccelerating across regions. In the U.S., Klarna raised $1.37 billion, StubHub targets up to $851 million, and Via priced a $493 million debut, with IPOX VP Kat Liu highlighting brand power and public-sector risks. Europe features SMG Swiss Marketplace Group’s CHF 43–46 range and NOBA’s planned Stockholm float. Asia-Pacific sees Zijin Gold’s about $3 billion Hong Kong deal, Hesai’s raise, and Big Caring and Butong. MENA adds Bateel’s planned Riyadh listing.

In the U.S., StubHub and Netskope prepare billion-dollar IPOs, while Advent eyes a $12 billion listing of Innio. Asia sees Zijin Gold’s $3 billion Hong Kong debut and Chery Auto’s $2 billion approval. Europe features Rolls-Royce exploring an SMR IPO and Czech grocer Rohlik weighing listing. In MENA, Sabic slows its gas unit IPO, while Gulf Cryo considers options.

Global IPO momentum is building into September. In the U.S., Klarna and Netskope target ~$1bn raises, alongside Pattern, Andersen, Avant, Lendbuzz and a $250m SPAC. Canada’s GO Residential REIT shows mixed sentiment. Europe eyes a Frankfurt–Zurich revival, with Stada watching conditions. Asia-Pacific features Chery’s $1.5–$2bn HK float, a >$1bn Singapore REIT, Japan’s Tekscend, Hesai, and Korean deals. MENA sees Jamjoom’s Nomu filing and Abu Dhabi–registered Uzum plotting a 2027 IPO.

U.S. IPO momentum is surging with WaterBridge, Pattern, Figure, and Gemini filings, while Fannie Mae and Freddie Mac prepare a potential $30B share sale. Europe sees TenneT’s €12B IPO and Zurich’s SMG listing plans. In Asia-Pacific, Aux Electric eyes a $600M Hong Kong deal, alongside Hesai, Edge Medical, and Miniso’s Top Toy. Saudi Arabia’s Dar Al Majed raised $336M, underscoring strong institutional demand despite weaker retail appetite.